USP9YP16

Across TCGA patient cohorts, USP9YP16 RNA expression is significantly associated with the go_rna of many other GO terms, with 9 significant associations in total. STAD shows the largest number of these associations.

The most reproducible USP9YP16-associated GO terms across cancer lineages are Adenylate cyclase-activating dopamine receptor signaling pathway, Synaptic transmission, glutamatergic, and Prolactin secretion. Each is linked with USP9YP16 in more than 1 cancer types. Because this analysis shows association rather than direction, both USP9YP16-to-partner and partner-to-USP9YP16 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Adenylate cyclase-activating dopamine receptor signaling pathway grouped by USP9YP16-low versus USP9YP16-high in OV.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (USP9YP16→partner) and Y-score (partner→USP9YP16) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
OV	Adenylate cyclase-activating dopamine receptor signaling pathway →	+0.081	+0.010	.002	.005	2	1
STAD	Synaptic transmission, glutamatergic →	+0.038	+0.017	.002	<.001	2	1
STAD	Prolactin secretion →	+0.117	+0.012	.001	.005	2	1
STAD	Positive regulation of gap junction assembly →	+0.106	+0.007	.003	.006	1	1
STAD	tRNA threonylcarbamoyladenosine modification →	+0.060	+0.011	.003	.008	1	1
STAD	Cell migration involved in gastrulation →	+0.081	+0.008	<.001	.002	1	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 9 associations by consensus.

Adenylate cyclase-activating dopamine receptor signaling pathway by USP9YP16 expression — OV

Explore this box plot interactively →